AI is no longer a roadmap item; it's a commercial imperative. Across Europe's pharma landscape, the organisations pulling ahead are those that have stopped experimenting and started executing turning fragmented data into intelligence engines, embedding AI into the workflows that drive revenue, and building the infrastructure that makes it all scale. The gap between those teams and everyone else is widening fast. And it won't wait. Reuters Events: Pharma Commercial Data and Tech 2026 is where Europe's most senior pharma commercial, data, and digital leaders come together to close that gap. With around 250 attendees, this is an exclusive, high-level gathering, not a trade show floor, but a room of peers who are navigating the same pressures, making the same bets, and willing to be honest about what's working and what isn't. Expect bold conversations on transforming CRM systems from glorified contact databases into dynamic commercial intelligence engines, ones that predict opportunities, surface real-time insights at the point of engagement, and serve as the execution layer for agentic AI. Expect a hard look at what precision customer engagement actually means when HCP and patient expectations are shifting beneath your feet, and AI is reshaping how health information is sought, trusted, and acted upon. Expect a frank discussion on the data infrastructure decisions being made right now that will determine who is AI-ready in 2027, and who is still untangling governance frameworks while competitors scale.

Description supplied by the event organiser.